Document is current

Any future updates will be listed below

Chemotherapy-associated treatment burden in breast cancer patients receiving lipegfilgrastim or pegfilgrastim: secondary efficacy data from a phase III study

Crossref DOI link: https://doi.org/10.1007/s00520-015-2803-9

Published Online: 2015-06-20

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark